Global Alzheimer's Drugs Market Forecasts 2017-2021

Report : Global Alzheimer's Drugs Market 2017-2021 is a new market research publication announced by Reportstack. 

Report Outline: Alzheimer's disease is a progressive and irreversible degeneration of the brain that disrupts the thinking, language, behavior, and cognitive skills of a person. It is more prevalent in people aged 65 years and above and affects more women than men. As per the Centers for Disease Control and Prevention (CDC), 5.4 million Americans are affected by this disease, and the incidence rate of disease increases with age and doubles every five years for adults beyond 65 years of age.

For detailed report with TOC, please click here ​Global Alzheimer's Drugs Market 2017-2021

Market Growth: The global alzheimer's drugs market to grow at a CAGR of 1.90% during the period 2017-2021.

Key vendors • ALLERGAN
• Eisai Pharmaceuticals
• Johnson & Johnson
• Novartis

Other prominent vendors • Amgen
• Pfizer

Regions Covered:

• Americas
• APAC
• EMEA

Companies Mentioned

ALLERGAN, Eisai Pharmaceuticals, Johnson & Johnson, and Novartis. Amgen, and Pfizer.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###